Cutaneous Markers of Cardiovascular Diseases

Cláudia Brazão; Rita Pimenta; Catarina Queirós; Paulo Filipe; Luiz Menezes Falcão

doi:10.20344/amp.18108

Autores

Cláudia Brazão Serviço de Dermatovenereologia. Hospital de Santa Maria. Centro Hospitalar Universitário Lisboa Norte. Lisboa.
Rita Pimenta Serviço de Dermatovenereologia. Hospital Garcia de Orta. Almada.
Catarina Queirós Serviço de Dermatovenereologia. Hospital de Santa Maria. Centro Hospitalar Universitário Lisboa Norte. Lisboa.
Paulo Filipe Serviço de Dermatovenereologia. Hospital de Santa Maria. Centro Hospitalar Universitário Lisboa Norte. Lisboa. Clínica Universitária de Dermatovenereologia. Faculdade de Medicina. Universidade de Lisboa. Lisboa.
Luiz Menezes Falcão Serviço de Medicina Interna. Hospital de Santa Maria. Centro Hospitalar Universitário Lisboa Norte. Lisboa. Clínica Universitária de Medicina Interna. Faculdade de Medicina. Universidade de Lisboa. Lisboa.

DOI:

https://doi.org/10.20344/amp.18108

Palavras-chave:

Doenças Cardiovasculares, Manifestações Cutâneas

Resumo

As doenças cardiovasculares são um dos desafios médicos mais importantes a nível mundial devido às suas elevadas taxas de morbilidade e mortalidade. Neste artigo, é feita uma revisão das manifestações cutâneas mais importantes que poderão estar presentes em doentes com doenças cardiovasculares. O reconhecimento atempado destas entidades clínicas é fulcral, uma vez que permite um diagnóstico e tratamento precoces, minimizando os efeitos destas doenças a longo prazo e possivelmente melhorando o prognóstico destes doentes.

Downloads

Não há dados estatísticos.

Referências

Dahlöf B. Cardiovascular disease risk factors: epidemiology and risk assessment. Am J Cardiol. 2010;105:3A-9. DOI: https://doi.org/10.1016/j.amjcard.2009.10.007

Saksena F. Local and systemic manifestations of cardiovascular disease. In: Ranganattan NSivaciyan V, Saksena F, editors. The art and science of cardiac physical examination. New Jersey: Humana Press; 2007. p.361-95. DOI: https://doi.org/10.1007/978-1-59745-023-2_11

Uliasz A, Lebwohl M. Cutaneous manifestations of cardiovascular diseases. Clin Dermatol. 2008;26:243-54. DOI: https://doi.org/10.1016/j.clindermatol.2007.10.014

Mcdonnell JK. Cardiac disease and the skin. Dermatol Clin. 2002;20:503-11. DOI: https://doi.org/10.1016/S0733-8635(02)00007-4

Chan HL. Cutaneous manifestations of cardiac diseases. Singapore Med J. 1990;31:480-85.

Trayes KP, Studdiford JS. Edema: diagnosis and management. Am Fam Physician. 2013;88:102-10.

O’Gara PT, Loscalzo J. Physical examination of the cardiovascular system. In: Jameson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL, Loscalzo J, editors. Harrison’s principles of Internal Medicine. 20th ed. New York: McGraw-Hill; 2018 p.1666-75.

Inamdar A, Inamdar A. Heart failure: diagnosis, management and utilization. J Clin Med. 2016;5:62. DOI: https://doi.org/10.3390/jcm5070062

Stone J, Hangge P, Albadawi H, Wallace A, Shamoun F, Knuttien M, et al. Deep vein thrombosis: pathogenesis, diagnosis, and medical management. Cardiovasc Diagn Ther. 2017;7:S277-84. DOI: https://doi.org/10.21037/cdt.2017.09.01

O’Gara PT, Loscalzo J. Hypoxia and cyanosis. In: Jameson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL, Loscalzo J, editors. Harrison’s principles of Internal Medicine. 20th ed. New York: McGraw-Hill; 2018.p.234-7.

Spicknall KE, Zirwas MJ, English JC. Clubbing: an update on diagnosis, differential diagnosis, pathophysiology, and clinical relevance. J Am Acad Dermatol. 2005;52:1020-8. DOI: https://doi.org/10.1016/j.jaad.2005.01.006

Malakar AK, Choudhury D, Halder B, Paul P, Uddin A, Chakraborty S. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019;234:1-12. DOI: https://doi.org/10.1002/jcp.28350

Dwivedi S. Cutaneous markers of coronary artery disease. World J Cardiol. 2010;2:262. DOI: https://doi.org/10.4330/wjc.v2.i9.262

Wagner Jr RF, Wagner KD. Cutaneous signs of coronary artery disease. Int J Dermatol. 1983;22:215-20. DOI: https://doi.org/10.1111/j.1365-4362.1983.tb03370.x

Schwarzenberger K, Callen J. Dermatologic manifestations in patients with systemic disease. In: Bolognia JL, Schaffer JV, Cerroni L, editors. Dermatology. 4th ed. Amsterdam: Elsevier; 2018:819-43.

Forrestel A, Micheletti R. Skin manifestations of internal organ disorders. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, Michael AJ, et al, editors. Fitzpatrick’s dermatology. 9th ed. New York: McGraw-Hill; 2019:2425-40.

Davis TM, Stuccio G, Balme M, Bruce DG, Jackson D. The diagonal ear lobe crease (Frank’s sign) is not associated with coronary artery disease or retinopathy in type 2 diabetes: the Frernantle Diabetes Study. Aust N Z J Med. 2000;30:573-7. DOI: https://doi.org/10.1111/j.1445-5994.2000.tb00858.x

Frank ST. Aural sign of coronary artery disease. N Engl J Med. 1973;289:327-8. DOI: https://doi.org/10.1056/NEJM197308092890622

Shoenfeld Y, Mor R, Weinberger A, Pinkhas J. Diagonal ear lobe crease and coronary risk factors. J Am Geriatr Soc. 1980;28:184-7. DOI: https://doi.org/10.1111/j.1532-5415.1980.tb00514.x

Sanches MM, Roda Â, Pimenta R, Filipe PL, Freitas JP. Cutaneous manifestations of diabetes mellitus and prediabetes. Acta Med Port. 2019;32:459-65. DOI: https://doi.org/10.20344/amp.10738

Carabello BA. Modern management of mitral stenosis. Circulation. 2005;112:432-7. DOI: https://doi.org/10.1161/CIRCULATIONAHA.104.532498

Akinseye OA, Pathak A, Ibebuogu UN. Aortic valve regurgitation: a comprehensive review. Curr Probl Cardiol. 2018;43:315-34. DOI: https://doi.org/10.1016/j.cpcardiol.2017.10.004

Iung B, Duval X. Infective endocarditis: innovations in the management of an old disease. Nat Rev Cardiol. 2019;16:623-35. DOI: https://doi.org/10.1038/s41569-019-0215-0

Servy A, Valeyrie-Allanore L, Alla F, Lechiche C, Nazeyrollas P, Chidiac C, et al. Prognostic value of skin manifestations of infective endocarditis. JAMA Dermatol. 2014;150:494-500. DOI: https://doi.org/10.1001/jamadermatol.2013.8727

Gunson TH, Oliver GF. Osler’s nodes and Janeway lesions. Australas J Dermatol. 2007;48:251-5. DOI: https://doi.org/10.1111/j.1440-0960.2007.00397.x

Pepe G, Giusti B, Sticchi E, Abbate R, Gensini GF, Nistri S. Marfan syndrome: current perspectives. Appl Clin Genet. 2016;9:55-65. DOI: https://doi.org/10.2147/TACG.S96233

Pyeritz RE. The Marfan syndrome. Annu Rev Med. 2000;51:481-510. 28. Sulli A, Talarico R, Scirè CA, Avcin T, Castori M, Ferraris A, et al. Ehlers-Danlos syndromes: state of the art on clinical practice guidelines. RMD Open. 2018;4:1-6. DOI: https://doi.org/10.1136/rmdopen-2018-000790

Beighton P. The dominant and recessive forms of cutis laxa. J Med Genet. 1972;9:216-21. DOI: https://doi.org/10.1136/jmg.9.2.216

Mohamed M, Voet M, Gardeitchik T, Morava E. Cutis laxa. Adv Exp Med Biol. 2014;802:161-84. DOI: https://doi.org/10.1007/978-94-007-7893-1_11

Stumpf MJ, Schahab N, Nickenig G, Skowasch D, Schaefer CA. Therapy of pseudoxanthoma elasticum: current knowledge and future perspectives. Biomedicines. 2021;9:1895. DOI: https://doi.org/10.3390/biomedicines9121895

Denayer E, Legius E. What’s new in the neuro-cardio-facial-cutaneous syndromes? Eur J Pediatr. 2007;166:1091-8. DOI: https://doi.org/10.1007/s00431-007-0535-7

Sundaresan S, Migden MR, Silapunt S. Stasis dermatitis: pathophysiology, evaluation, and management. Am J Clin Dermatol. 2017;18:383-90. DOI: https://doi.org/10.1007/s40257-016-0250-0

Nicholls SC. Sequelae of untreated venous insufficiency. Semin Intervent Radiol. 2005;22:162-8. DOI: https://doi.org/10.1055/s-2005-921960

Santler B, Goerge T. Chronic venous insufficiency – a review of pathophysiology, diagnosis, and treatment. J Dtsch Dermatol Ges. 2017;15:538-56. DOI: https://doi.org/10.1111/ddg.13242

Herouy Y, Mellios P, Bandemir E, Dichmann S, Nockowski P, Schopf E, et al. Inflammation in stasis dermatitis upregulates MMP-1, MMP-2 and MMP-13 expression. J Dermatol Sci. 2001;25:198-205. DOI: https://doi.org/10.1016/S0923-1811(00)00128-6

Weaver J, Billings SD. Initial presentation of stasis dermatitis mimicking solitary lesions: a previously unrecognized clinical scenario. J Am Acad Dermatol. 2009;61:1028-32. DOI: https://doi.org/10.1016/j.jaad.2009.04.025

Francès C, Niang S, Laffitte E, le Pelletier F, Costedoat N, Piette JC. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum. 2005;52:1785-93. DOI: https://doi.org/10.1002/art.21041

Schreiber K, Sciascia S, de Groot PG, Devreese K, Jacobsen S, Ruiz-Irastorza G, et al. Antiphospholipid syndrome. Nat Rev Dis Primers. 2018;4. DOI: https://doi.org/10.1038/nrdp.2017.103

Pinto-Almeida T, Caetano M, Sanches M, Selores M. Cutaneous manifestations of antiphospholipid syndrome: a review of the clinical features, diagnosis and management. Acta Reumatol Port. 2013;32:10-8.

Carapetis JR, Beaton A, Cunningham MW, Guilherme L, Karthikeyan G, Mayosi BM, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers. 2016;2:1-24. DOI: https://doi.org/10.1038/nrdp.2015.84

Cunningham MW. Molecular mimicry, autoimmunity, and infection: the cross-reactive antigens of group a streptococci and their sequelae. Microbiol Spectr. 2019;7:10.1128/microbiolspec.GPP3-0045-2018. DOI: https://doi.org/10.1128/microbiolspec.GPP3-0045-2018

Gewitz MH, Baltimore RS, Tani LY, Sable CA, Shulman ST, Carapetis J, et al. Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography a scientific statement from the American heart association. Circulation. 2015;131:1806-18. DOI: https://doi.org/10.1161/CIR.0000000000000205

Ghanem KG, Ram S, Rice PA. The modern epidemic of syphilis. N Engl J Med. 2020;382:845-54. DOI: https://doi.org/10.1056/NEJMra1901593

Lukehart S. Syphilis. In: Jameson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL, Loscalzo J, editors. Harrison’s principles of Internal Medicine. 20th ed. New York: McGraw-Hill; 2018. p.1279-86.

Kreps A, Paltoo K, McFarlane I. Cardiac manifestations in systemic lupus erythematosus: a case report and review of the literature. Am J Med Case Rep. 2018;6:180-3. DOI: https://doi.org/10.12691/ajmcr-6-9-3

Jarrett P, Werth VP. A review of cutaneous lupus erythematosus: improving outcomes with a multidisciplinary approach. J Multidiscip

Healthc. 2019;12:419-28.

Jain D, Halushka MK. Cardiac pathology of systemic lupus erythematosus. J Clin Pathol. 2009;62:584-92. DOI: https://doi.org/10.1136/jcp.2009.064311

Dietz SM, van Stijn D, Burgner D, Levin M, Kuipers IM, Hutten BA, et al. Dissecting Kawasaki disease: a state-of-the-art review. Eur J Pediatr. 2017;176:995-1009. DOI: https://doi.org/10.1007/s00431-017-2937-5

Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2743-71. DOI: https://doi.org/10.1161/01.CIR.0000145143.19711.78

Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390:1685-99. DOI: https://doi.org/10.1016/S0140-6736(17)30933-9

Bargagli E, Prasse A. Sarcoidosis: a review for the internist. Intern Emerg Med. 2018;13:325-31. DOI: https://doi.org/10.1007/s11739-017-1778-6

Katta R. Cutaneous sarcoidosis: a dermatologic masquerader. Am Fam Physician. 2002;5:1581-4.

DeWane ME, Waldman R, Lu J. Dermatomyositis: clinical features and pathogenesis. J Am Acad Dermatol. 2020;82:267-81. DOI: https://doi.org/10.1016/j.jaad.2019.06.1309

Waldman R, DeWane ME, Lu J. Dermatomyositis: diagnosis and treatment. J Am Acad Dermatol. 2020;82:283-96. DOI: https://doi.org/10.1016/j.jaad.2019.05.105

Hruza LL, Hruza GJ. Saphenous vein graft donor site dermatitis case reports and literature review. Arch Dermatol. 1993;129:609-12. DOI: https://doi.org/10.1001/archderm.129.5.609

Frishman WH, Brosnan BD, Grossman M, Dasgupta D, Sun DK. Adverse dermatologic effects of cardiovascular drug therapy: part I. Cardiol Rev. 2002;10:230-46. DOI: https://doi.org/10.1097/00045415-200207000-00008

Frishman WH, Brosnan BD, Grossman M, Dasgupta D, Sun DK. Adverse dermatologic effects of cardiovascular drug therapy: part II. Cardiol Rev. 2002;10:285-300. DOI: https://doi.org/10.1097/00045415-200209000-00005

Frishman WH, Brosnan BD, Grossman M, Dasgupta D, Sun DK. Adverse dermatologic effects of cardiovascular drug therapy: part III. Cardiol Rev. 2002;10:337-48. DOI: https://doi.org/10.1097/00045415-200211000-00006